and toxoplasmastatic activity in murine interleukin 6, reactive nitrogen intermediates, induces tumor necrosis factor alpha and Mycobacterial 65-kilodalton heat shock protein http://iai.asm.org/content/63/9/3454 Updated information and services can be found at: The 65-kDa heat shock protein (Hsp65) is supposed to play a role in host defense against infections with various microbial pathogens and in autoimmune inflammatory disorders. These effects are thought to result mainly from an Hsp65-specific T-lymphocyte-mediated immune response that recognizes conserved epitopes. The aim of the present study was to assess whether mycobacterial Hsp65 has a direct effect on resident murine peritoneal macrophages, independent of Hsp65-sensitized T lymphocytes. Exposure of peritoneal macrophages from naive C57BL/6 mice to the mycobacterial Hsp65 in vitro induced an enhanced release of tumor necrosis factor alpha (TNF-␣) and interleukin 6. These cells also produced large amounts of reactive nitrogen intermediates (RNI) and inhibited the intracellular proliferation of Toxoplasma gondii. Small amounts of gamma interferon acted synergistically with Hsp65. Thus, exposure of murine macrophages to Hsp65 results in activation of these cells. The acquisition of these characteristics by peritoneal macrophages occurred in the absence of sensitized T lymphocytes. Addition of anti-TNF-␣ antiserum resulted in an attenuation of the Hsp65-induced release of RNI and toxoplasmastatic activity, indicating that endogenous TNF-␣ is involved in the Hsp65-induced macrophage activation. The conclusion of this study is that in vitro exposure of peritoneal macrophages to the mycobacterial Hsp65 induces the release of proinflammatory cytokines and RNI and results in inhibition of the intracellular proliferation of T. gondii. These effects on murine macrophages occur independently of Hsp65-specific T lymphocytes. The proinflammatory effect of Hsp65 demonstrated in this study suggests that this heat shock protein may play a role in the initiation of inflammation that adds to a non-species-specific resistance in the early stages of infections.
Heat shock proteins are constitutively present in eucaryotic and procaryotic cells. The production of heat shock proteins is greatly enhanced by stress stimuli such as a rise in temperature, exposure to toxic oxygen radicals, and nutritional deficiencies. The main function of heat shock proteins is preservation of essential cellular proteins and functions. The mycobacterial 65-kDa heat shock protein (Hsp65) belongs to the major 60-kDa heat shock protein family that displays a high degree of genotypic and phenotypic homology among various microorganisms and the human counterpart (12, 13, 17, 28, 34) . Hsp65 is an immunodominant antigen that elicits a strong humoral and cellular immune response. Hsp65 may participate in the host defense against invading microorganisms and may also play a role in immune inflammatory disorders such as arthritis, diabetes mellitus, and Crohn's disease. These effects are thought to result mainly from an Hsp65-specific T-lymphocytemediated immunity that recognizes conserved epitopes (9, 15, 16, 24, 25, 31) . Recently, it has been shown that in vitro exposure of human monocytes and monocyte-derived macrophages to mycobacterial Hsp65 induces the release of proinflammatory cytokines, such as tumor necrosis factor alpha (TNF-␣) and interleukin-1␤ (IL-1␤). The enhanced release of proinflammatory cytokines by these cells occurred in the absence of Hsp65-sensitized T lymphocytes (11, 26) . TNF-␣, together with gamma interferon (IFN-␥), can act as an autocrine signal to augment the microbicidal effector functions of macrophages (18, 19, 21) .
Hsp65 homologs are abundantly expressed in inflammatory lesions and produced by microorganisms during invasive infection and phagocytosis (6, 24) . Our hypothesis is that Hsp65 is involved in the pathogenesis of various inflammatory diseases and adds to a first-line host defense against invasive pathogens by its capacity to induce the endogenous production of proinflammatory cytokines, which in turn activate antimicrobial functions of mononuclear phagocytes. The aim of the present study was to assess whether exposure of murine macrophages to Hsp65 has a direct effect on the functions of these cells, independent of Hsp65-sensitized T lymphocytes.
saline and stored at Ϫ70ЊC, and aliquots were thawed only once, immediately before use. The LPS content of these solutions was Ͻ0.35 ng per mg of protein.
Aliquots of a rabbit anti-mouse TNF-␣ antiserum (generously provided by Innogenetics, Ghent, Belgium) containing approximately 10 6 neutralizing units per ml and of normal rabbit serum as controls were stored at Ϫ70ЊC and thawed immediately before use. Neutralizing monoclonal antibody specific for rat and mouse IFN-␥ (DB1) (30) containing 5 ϫ 10 3 neutralizing units per mg (gift from P. H. van der Meide) was stored in aliquots at Ϫ70ЊC and thawed immediately before use.
Isolation and stimulation of peritoneal macrophages. Resident peritoneal macrophages were harvested by lavage of the peritoneal cavities of mice with 2 ml of ice-cold phosphate-buffered saline (PBS) containing 50 U of heparin per ml as described previously (32) . The cells were washed with ice-cold PBS containing 0.5 U of heparin per ml and counted in a Bürker hemocytometer. The macrophages were suspended to a concentration of 10 6 /ml in sterile LPS-free RPMI 1640 medium (Flow Laboratories, Irvine, Scotland) supplemented with 10% heat-inactivated (30 min, 56ЊC) fetal bovine serum (Gibco BRL, Paisley, United Kingdom), 1,000 U of sodium penicillin G (Brocades Pharma B.V., Leiderdorp, The Netherlands) per ml, 50 g of streptomycin (Biochemie GmbH, Vienna, Austria) per ml, and 2 mM L-glutamine (Flow Laboratories, Irvine, Scotland), hereafter called medium. The LPS content of the medium was Ͻ0.08 ng/ml. One milliliter of the cell suspension was plated on 35-mm-diameter tissue culture dishes (Falcon, Plymouth, England) containing three 12-mm-diameter round glass coverslips and incubated for 1 h at 37ЊC and 7.5% CO 2 . Nonadherent cells were removed by washing, and the adherent macrophages were incubated with 1 ml of medium containing 50, 10, 1, or 0.1 g of Hsp65, 10 g of ovalbumin, or 100 U of rIFN-␥ plus 10 ng of Escherichia coli LPS (O11:B4; Sigma, St. Louis, Mo.). After incubation for 3 and 24 h, samples were taken from the cell culture supernatants and processed immediately. After incubation for 24 h, the intracellular proliferation of Toxoplasma gondii in the macrophages was assessed.
Measurement of cytokine production. The production of TNF-␣ was determined by means of an enzyme-linked immunosorbent assay (ELISA). A 96-well Nunc-Immuno plate (Nunc, Roskilde, Denmark) was coated overnight at 4ЊC with 2 g of rat anti-mouse TNF-␣ monoclonal antibody (Pharmingen, San Diego, Calif.) per ml in a volume of 100 l of coating buffer (25 mM Na 2 CO 3 , 25 mM NaHCO 3 , 0.02% sodium azide, pH 9.6). The wells were washed three times with PBS containing 0.05% Tween 20 (PBS-Tween) and next incubated for 2 h at room temperature with 200 l of PBS containing 10% heat-inactivated newborn calf serum (Gibco) (PBS-NBCS i ). After the wells were washed three times, 100 l of cell-free supernatant sampled after 3 h of incubation of the macrophages or 100 l of standard rTNF-␣ dilutions was added in triplicate and incubated overnight at 4ЊC. The wells were washed with PBS-Tween and subsequently incubated with 1 g of biotinylated rat anti-mouse TNF-␣ monoclonal antibody per ml in a volume of 100 l of PBS-NBCS i during 45 min at room temperature. After being washed, the wells were incubated with 100 l of PBS-NBCS i containing 0.25 g of streptavidin-peroxidase (Sigma) per ml during 1 h at room temperature. The wells were thoroughly washed, and 100 l of sodiumacetate buffer (pH 6.0) containing 0.02% (vol/vol) H 2 O 2 and 0.1 mg of 3,3Ј,5,5Ј-tetramethylbenzidine (Sigma) per ml was added. After 15 min of incubation at room temperature, the reaction was stopped and A 450 were read on a Titertek Multiscan Plus (EFLAB, Helsinki, Finland).
The level of production of IFN-␥ was determined by ELISA (generously provided by P. H. van der Meide). In short, a 96-well plate (Titertek Immunoassay plate; Flow Laboratories) was coated overnight at 4ЊC with 15 g of anti-IFN-␥ (DB1) per ml in a volume of 100 l of PBS (pH 8.2). After being washed with Tris-buffered saline containing 0.05% Tween 20, the wells were incubated with 200 l of PBS containing 2% bovine serum albumin. Next, 100 l of cell-free supernatant sampled after 24 h of incubation of the macrophages or standard rat IFN-␥ dilutions (Biological Primate Research Center) was added after washing and incubated for 2 h at 37ЊC. After the wells were washed, 100 l of PBS containing 60 ng of biotinylated rabbit anti-rat IFN-␥ antibodies was added and the wells were incubated for 1 h at 37ЊC; next, the wells were washed and 100 l of saline containing 250 mU of anti-biotin alkaline phosphatase (Boehringer GmbH, Mannheim, Germany) was added. After incubation for 1 h at 37ЊC, the wells were washed, 100 l of substrate buffer (1 M glycine, 10 mM ZnCl 2 , 10 mM MgCl 2 ) containing 50 g of p-nitrophenylphosphate (Sigma) was added, and the wells were incubated for 30 min at 37ЊC. After the addition of 30 l of 3 N NaOH, the A 405 was read on a Titertek Multiscan Plus (EFLAB).
The production of IL-6 by peritoneal macrophages was assessed by the B-9 bioassay (33) .
Measurement of nitrite production. The amount of nitrite (NO 2 Ϫ ) released by peritoneal macrophages after 24 h of incubation was measured in cell-free supernatants by the colorimetric Griess reaction as previously described (1, 8) . In short, 50 l of the supernatant was mixed with 50 l of Griess reagent consisting of 1% sulfanylamide, 0.1% naphthylethylene-diamide-dihydrochloride, and 2.5% H 3 PO 4 and incubated for 10 min at room temperature. A 550 of the reaction product reflecting the concentration of NO 2 Ϫ were read on a Titertek Multiscan Plus. All measurements were performed in triplicate, and the results are expressed in nanomoles of NO 2 Ϫ per 10 6 macrophages. Intracellular proliferation of T. gondii. The virulent RH strain of T. gondii was maintained by biweekly intraperitoneal passage in mice. After collection of the tachyzoites by peritoneal lavage, peritoneal macrophages were infected with T. gondii as described previously (18, 25) . In brief, macrophages were suspended in medium at a concentration of 10 6 /ml. Two milliliters was plated on 35-mmdiameter plastic culture dishes (Falcon) containing three 12-mm-diameter round glass coverslips and incubated for 2 h at 37ЊC and 7.5% CO 2 . Nonadherent cells were removed by washing. Next, the adherent macrophages were incubated with 1 ml of medium containing 10 6 toxoplasmas per ml for 30 min at 37ЊC and 7.5% CO 2 and then washed three times with warm PBS to remove noningested toxoplasmas. The experimental conditions were chosen so that 25 to 30% of the macrophages would be infected. One coverslip was fixed in methanol and stained with Giemsa stain for determination of the number of ingested protozoa and the percentage of infected macrophages at the start of the assay. Fresh medium was added to the cells on the other coverslips, and they were incubated for another 18 h at 37ЊC and 7.5% CO 2 . After fixation of the cells in methanol and staining with Giemsa stain, the number of toxoplasmas per 100 macrophages was determined microscopically. The results of the assay are expressed as the fold increase, i.e., the ratio of the mean number of toxoplasmas per 100 macrophages after 18 h of incubation to the mean number of toxoplasmas per 100 macrophages at 0 h.
Statistical analysis. The results are expressed as means Ϯ standard deviations of at least four independent experiments. The significance of differences in values was assessed by Student's paired t test. The level of significance was set at 0.05.
RESULTS
Production of proinflammatory cytokines by peritoneal macrophages after in vitro stimulation with Hsp65. The amount of TNF-␣ produced by 10 6 peritoneal macrophages of C57BL/6 mice after 3 h of incubation with 10 and 50 g of Hsp65 per ml in vitro was significantly higher than that produced by peritoneal macrophages incubated with 10 g of ovalbumin per ml or incubated in medium only (referred to as the controls) (P Ͻ 0.005 and P Ͻ 0.001, respectively) (Fig. 1A) . Lower concentrations of Hsp65, i.e., 1 and 0.1 g per ml, did not (P Ͼ 0.05) induce an enhanced production of TNF relative to that produced by control macrophages. Ovalbumin, which served as a control protein, did not (P Ͼ 0.2) induce an enhanced production of TNF-␣ by macrophages compared with the result for macrophages incubated in medium only.
Since IFN-␥ with or without LPS stimulates macrophages to release proinflammatory cytokines (18) , the release of TNF-␣ by peritoneal macrophages stimulated in vitro with 100 U of IFN-␥ per ml together with 10 ng of LPS per ml was assessed and compared with Hsp65 stimulation. The amount of TNF-␣ produced by IFN-␥-and-LPS-stimulated peritoneal macrophages was not significantly different (P Ͼ 0.05) from that produced by peritoneal macrophages stimulated with 10 or 50 g of Hsp65 per ml but was significantly (P Ͻ 0.001) enhanced relative to that produced by the controls (Fig. 1A) .
Peritoneal macrophages that were incubated for 24 h with 50 g of Hsp65 per ml produced significantly (P Ͻ 0.01) more IL-6 than peritoneal macrophages incubated with ovalbumin or incubated in medium only. In vitro incubation of peritoneal macrophages with 10 g of Hsp65 per ml or with IFN-␥ together with LPS also resulted in an enhanced production of IL-6 compared with that produced by the controls (Fig. 1B) . The amount of IL-6 released by macrophages during stimulation with IFN-␥ together with LPS was similar to that released during stimulation with 10 or 50 g of Hsp65 per ml. Ovalbumin did not induce an enhanced production of IL-6 compared with that produced by macrophages incubated in medium only.
Incubation of the cells with 10 g of Hsp65 per ml for 24 h did not induce detectable amounts of IFN-␥.
Production of NO 2 ؊ by peritoneal macrophages after in vitro stimulation with Hsp65. During in vitro incubation with 10 and 50 g of Hsp65 per ml for 24 h, peritoneal macrophages produced significantly (P Ͻ 0.005) more NO 2 Ϫ than they produced during incubation with ovalbumin or in medium only ( Table 1 ). The amount of NO 2 Ϫ produced by peritoneal macrophages incubated with 1 or 0.1 g of Hsp65 per ml did not differ from that produced by the controls (P Ͼ 0.05). Ovalbumin did not induce an enhanced production of NO 2 Ϫ by mac- rophages, compared with that produced by macrophages incubated in medium only. In vitro incubation of peritoneal macrophages with IFN-␥ together with LPS resulted in a larger production of NO 2 Ϫ compared with that of macrophages stimulated with Hsp65 (P Ͻ 0.01) and that of the controls (Table 1) . Small amounts of IFN-␥ acted synergistically with Hsp65 in the induction of NO 2 Ϫ by the peritoneal macrophages ( Table 2 ). To exclude the possibility that some of the effects of Hsp65 on macrophages are mediated by contaminating cells, e.g., NK cells, that might produce IFN-␥ upon incubation with the heat shock protein, neutralizing antibodies against IFN-␥ were added. During incubation of macrophages with 10 g of Hsp65 in the presence of 100 g of anti-IFN-␥ per ml, the amount of NO 2 Ϫ (16.6 Ϯ 3.0 nmol/10 6 cells; n ϭ 4) released was the same as that released during incubation of macrophages with 10 g of Hsp65 per ml alone (16.8 Ϯ 5.0 nmol/10 6 cells; n ϭ 4). Furthermore, no IFN-␥ could be detected in the supernatants after 24 h of incubation with 10 g of Hsp65 per ml.
Intracellular proliferation of T. gondii in Hsp65-stimulated macrophages. In vitro incubation of peritoneal macrophages during 24 h with 10 or 50 g of Hsp65 per ml resulted in a significant (P Ͻ 0.05) inhibition of the intracellular proliferation of T. gondii compared with that for macrophages incubated with ovalbumin or incubated in medium only (Table 1) . Lower concentrations of Hsp65 did not inhibit the intracellular proliferation of T. gondii compared with the case for the controls (P Ͼ 0.1). The intracellular proliferation of T. gondii in peritoneal macrophages incubated with ovalbumin and that in peritoneal macrophages incubated in medium only were similar. Incubation of peritoneal macrophages with IFN-␥ together with LPS also resulted in inhibition of the intracellular proliferation of T. gondii, and the level of inhibition in this case was similar to that for peritoneal macrophages incubated with 50 g of Hsp65 per ml (P Ͼ 0.1).
Treatment of macrophages with Hsp65 did not affect the ability of T. gondii to invade the cells. The percentages of infected macrophages at the start of the assay after treatment with 50 g of Hsp65 per ml (23% Ϯ 4%) and 10 g of Hsp65 per ml (30% Ϯ 4%) were similar (P Ͼ 0.5) to that of ovalbumin-treated macrophages (28% Ϯ 6%) and macrophages incubated in medium only (26% Ϯ 4%). Also, the total number of tachyzoites at the start of the assay did not differ between the various treatment groups, i.e., 29 Ϯ 8, 36 Ϯ 7, 33 Ϯ 9, and 33 Ϯ 7 tachyzoites per 100 macrophages treated with 50 g of Hsp65 per ml, 10 g of Hsp65 per ml, and 10 g of ovalbumin per ml and incubated in medium only (controls), respectively.
Role of TNF-␣ in Hsp65-induced macrophage activation. Since TNF-␣ has been demonstrated to play an essential role in macrophage activation, we assessed the role of endogenously produced TNF-␣ in the Hsp65-induced macrophage activation. Neutralization of TNF-␣ by the addition of 10 c Data are expressed as fold increase in the number of T. gondii per 100 macrophages at 18 h. Results are means Ϯ standard deviations of six independent experiments.
d ‫,ء‬ significant (P Ͻ 0.05) difference from results for control macrophages incubated with ovalbumin or in medium only. intermediates (RNI) and the inhibition of T. gondii proliferation relative to that seen after incubation with Hsp65 in the presence of normal rabbit serum (Fig. 2) . The production of NO 2 Ϫ and the toxoplasmastatic activity of macrophages stimulated with Hsp65 in the presence of anti-TNF-␣ antibodies were similar to those for controls (P Ͼ 0.05).
DISCUSSION
The main conclusions from this study are that Hsp65 by itself induces activation of murine peritoneal macrophages, as judged by their ability to produce TNF-␣, IL-6, and RNI and to inhibit the intracellular proliferation of T. gondii. This Hsp65-induced macrophage activation is, at least in part, mediated by endogenously produced TNF-␣, since it is attenuated by neutralization of this cytokine. These results are obtained in the absence of sensitized T lymphocytes and represent a direct effect of Hsp65 on murine peritoneal macrophages. Incubation of peritoneal macrophages with ovalbumin, which served as a control protein, does not lead to macrophage activation, whereas incubation with IFN-␥ together with LPS induces functional characteristics in peritoneal macrophages similar to those induced by incubation with Hsp65.
The effects of Hsp65 on peritoneal macrophages cannot be attributed to contamination with LPS. The amount of LPS needed for a similar release of TNF-␣, increased toxoplasmastatic activity, and production of RNI by macrophages is much larger than that present in our preparations (5, 23) . Even in the synergistic combination with IFN-␥, a much higher LPS concentration was required to obtain comparable results. Moreover, others have shown that Hsp65 induces an LPS-independent enhancement of TNF gene expression and secretion of the protein by human THP-1 monocytic cells and that a concentration of at least 10 g of LPS per ml is required to obtain similar results (11) .
Our finding that antiserum to TNF-␣ significantly reduced the Hsp65-induced production of nitrite and toxoplasmastatic activity of murine macrophages is in agreement with earlier studies demonstrating that endogenous TNF-␣ is required for the production of RNI and subsequent induction of toxoplasmastatic activity in murine peritoneal macrophages (7, 18, 19) . Thus, it is suggested that Hsp65 directly induces the production of TNF-␣, which in turn leads to RNI production and enhanced antimicrobial activity of the macrophages.
Hsp65 induces the production of IL-6, and it has been demonstrated recently that this cytokine enhances the intracellular proliferation of T. gondii (3) . However, this effect of IL-6 on T. gondii proliferation is abrogated when TNF-␣ is added simultaneously (3). Hsp65 induces the production of both TNF-␣ and IL-6, which explains why T. gondii proliferation is inhibited despite the presence of large amounts of IL-6.
The observation that exposure to Hsp65 induces the secretion of the proinflammatory cytokines TNF-␣ and IL-6, increases the production of RNI, and inhibits the intracellular proliferation of T. gondii in peritoneal macrophages independently of sensitized T lymphocytes is surprising, since it is generally accepted that the effect of Hsp65 on host defense and autoimmune inflammatory disorders is due to an Hsp65-specific T-lymphocyte-mediated immune response. The latter view is not contradicted by our findings, but our results indicate that in addition to a T-lymphocyte-mediated immune reactivity to Hsp65, a direct effect of the exposure of mononuclear phagocytes to Hsp65 must be considered in the pathogenesis of inflammation.
Although we did not study the effects of Hsp65 derived from sources other than mycobacteria, this protein is highly conserved and has a high degree of homology among numerous microorganisms and even mammals (13, 28, 34) . Expression of Hsp65 by various microorganisms is greatly enhanced in the cases of phagocytosis (6) and exposure to toxic oxygen radicals (20) . Moreover, tissues that are affected by autoimmune inflammatory disorders also express the mammal counterpart of Hsp65 (14, 24) . Expression of Hsp65 is also induced by exposure of THP-1 monocytic cells to IFN-␥ and TNF-␣, and these cytokines act synergistically in this respect (10) . Our findings that Hsp65 by itself stimulates the release of TNF-␣, IL-6, and RNI by peritoneal macrophages suggest that Hsp65, proinflammatory cytokines, and reactive metabolites may mutually reinforce their effects on the inflammatory reaction. These inflammatory changes induced by Hsp65 may contribute to protection against microbial pathogens at an early stage of infection before a species-specific or Hsp65 antigen-specific immune response is generated. The possible protective role of Hsp65 during infections is stressed by the data of another study showing that expression of high levels of Hsp65 in macrophages correlates with protection against infection with T. gondii (22) . Also, the synergistic activity of small amounts of IFN-␥ and Hsp65 as observed in the present study indicates a protective role for Hsp65 early during infection.
Our findings may provide new insight into the role of Hsp65 in autoimmune inflammatory disorders. The release of TNF-␣ and RNI following exposure to Hsp65 may provoke both tissue damage (4) and an upregulation of self Hsp65. We reported recently that in intestinal lesions of Crohn's disease, self Hsp65 but not prokaryotic Hsp65 is abundantly expressed (24) . Others have found that T lymphocytes directed at self Hsp65 are generated in draining lymph nodes of a sterile inflammation without previous exposure to exogenous Hsp65 (2). Self Hsp65 upregulated in inflammatory lesions may then be recognized by sensitized T lymphocytes raised against cross-reactive epitopes on Hsp65 homologs from unrelated species, e.g., microorganisms, or raised against self Hsp65. The latter event may lead to an Hsp65-mediated autoimmune inflammatory reaction. The results of this study on the direct effect of Hsp65 on the functional characteristics of peritoneal macrophages provide further evidence for the hypothesis that Hsp65 may play a role in the initiation of the inflammatory process that accompanies infections with microbial pathogens and autoimmune disorders.
